Sopharma AD-Sofia's Total Assets for the quarter that ended in Jun. 2024 was лв1,483 Mil.
During the past 12 months, Sopharma AD-Sofia's average Total Assets Growth Rate was 9.30% per year.
During the past 3 years, the average Total Assets Growth Rate was 4.40% per year.
During the past 5 years, the average Total Assets Growth Rate was 5.50% per year.
During the past 10 years, the average Total Assets Growth Rate was 6.40% per year.
During the past 13 years, Sopharma AD-Sofia's highest 3-Year average Total Assets Growth Rate was 11.10%. The lowest was 2.40%. And the median was 6.15%.
The historical data trend for Sopharma AD-Sofia's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Sopharma AD-Sofia's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma AD-Sofia (XBUL:SFA) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Jun. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Sopharma AD-Sofia's Asset Turnover for the quarter that ended in Jun. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Sopharma AD-Sofia Total Assets Related Terms
Thank you for viewing the detailed overview of Sopharma AD-Sofia's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XBUL:SFA has been successfully added to your 